News
New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.
With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...
The Ohio attorney general's office issues warning letters to more than a dozen medical spas across the state for misleading claims about compounded versions of Ozempic, Wegovy and Mounjaro.
A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...
Illegal "weight loss injections" with dirty needles are being sold over social media and sent to people in Northern Ireland, ...
The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...
8don MSN
The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...
Investigators say Lewis Family Care’s weight loss clinic earned nearly $250,000 from administering the unapproved drug.
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
Three medical spas around the Valley, along with others in the state, were named by Attorney General Dave Yost for making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback